http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104055911-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36 |
| filingDate | 2013-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104055911-B |
| titleOfInvention | FUFANG EJIAO JIANG is prevented in preparation or is treated the application in the medicine of Human granulocytic anaplasmosis |
| abstract | The present invention relates to the application of FUFANG EJIAO JIANG in the medicine of preparation prevention or treatment Human granulocytic anaplasmosis, and by the pharmaceutical composition for preventing or treat Human granulocytic anaplasmosis preventing or treat the FUFANG EJIAO JIANG of upper effective dose and pharmaceutically acceptable carrier and form.The present invention is found by great many of experiments, FUFANG EJIAO JIANG can effectively reduce bring down a fever, hyperemia is disappeared, ooze out and disappear and time used that mucocutaneous hemorrhage stops, and obviously shortens the multiple normal time of platelet, leukocyte, blood urea nitrogen, creatinine and glutamate pyruvate transaminase. |
| priorityDate | 2013-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.